SEC Form 4 · accession 0001209191-18-022986
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Lerner
Director
Period of report
Mar 30, 2018
Accepted (ET)
Apr 3, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2018 | A | 653 | $21.05 | A | 10,223 | D | |
| Common StockF1 | holding | — | — | — | 53,000 | I | Held by the Lerner Family Trust UAD 11/14/94 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.